<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/A/Alpha-Interferon.html">
<title>Alpha_Interferon RSS : Gourt</title>
<link>http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/A/Alpha-Interferon.html</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:rights>Copyright 2007, Gourt.com</dc:rights>
<dc:date>2009-11-06T09:10+52:00
</dc:date>
<dc:publisher>rtruog@gourt.com</dc:publisher>
<dc:creator>rtruog@gourt.com</dc:creator>
<dc:subject>Alpha_Interferon RSS : Gourt</dc:subject>
<syn:updatePeriod>hourly</syn:updatePeriod>
<syn:updateFrequency>1</syn:updateFrequency>
<syn:updateBase>1901-01-01T00:00+00:00</syn:updateBase>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://twitter.com/CancerNewsNet/statuses/5471438422" />
  <rdf:li rdf:resource="http://twitter.com/PRNhealth/statuses/5462907312" />
  <rdf:li rdf:resource="http://twitter.com/PRNfinance/statuses/5462891470" />
  <rdf:li rdf:resource="http://twitter.com/tweetalot/statuses/5437474128" />
  <rdf:li rdf:resource="http://twitter.com/bohica74/statuses/5261054488" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://twitter.com/CancerNewsNet/statuses/5471438422">
<title>Cancer News Helix BioPharma completes enrollment in its Topical Interferon Alpha-2b ano-genital wart.. http://bit.ly/2uS4P6</title>
<link>http://twitter.com/CancerNewsNet/statuses/5471438422</link>
<description><![CDATA[Cancer News Helix BioPharma completes enrollment in its Topical Interferon Alpha-2b ano-genital wart.. http://bit.ly/2uS4P6]]></description>
</item>

<item rdf:about="http://twitter.com/PRNhealth/statuses/5462907312">
<title>Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Pati.. http://bit.ly/20j0dj
 #health</title>
<link>http://twitter.com/PRNhealth/statuses/5462907312</link>
<description><![CDATA[Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Pati.. http://bit.ly/20j0dj
 #health]]></description>
</item>

<item rdf:about="http://twitter.com/PRNfinance/statuses/5462891470">
<title>Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients Wit.. http://bit.ly/20j0dj</title>
<link>http://twitter.com/PRNfinance/statuses/5462891470</link>
<description><![CDATA[Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients Wit.. http://bit.ly/20j0dj]]></description>
</item>

<item rdf:about="http://twitter.com/tweetalot/statuses/5437474128">
<title>Method of treatment of viral hepatitis C with interferon alpha 5
 [6995133] http://bit.ly/1yU7Wi</title>
<link>http://twitter.com/tweetalot/statuses/5437474128</link>
<description><![CDATA[Method of treatment of viral hepatitis C with interferon alpha 5
 [6995133] http://bit.ly/1yU7Wi]]></description>
</item>

<item rdf:about="http://twitter.com/bohica74/statuses/5261054488">
<title>researching interferon alpha 2b. I wish it was for academic reasons. this time, it&#x27;s personal. Not as bad as typical chemo stories...maybe</title>
<link>http://twitter.com/bohica74/statuses/5261054488</link>
<description><![CDATA[researching interferon alpha 2b. I wish it was for academic reasons. this time, it&apos;s personal. Not as bad as typical chemo stories...maybe]]></description>
</item>

</rdf:RDF>